Synergistic effects of common schizophrenia risk variants
The mechanisms by which common risk variants of small effect interact to contribute to complex genetic disorders are unclear. Here, we apply a genetic approach, using isogenic human induced pluripotent stem cells, to evaluate the effects of schizophrenia (SZ)-associated common variants predicted to...
Saved in:
Published in | Nature genetics Vol. 51; no. 10; pp. 1475 - 1485 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Nature Publishing Group
01.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The mechanisms by which common risk variants of small effect interact to contribute to complex genetic disorders are unclear. Here, we apply a genetic approach, using isogenic human induced pluripotent stem cells, to evaluate the effects of schizophrenia (SZ)-associated common variants predicted to function as SZ expression quantitative trait loci (eQTLs). By integrating CRISPR-mediated gene editing, activation and repression technologies to study one putative SZ eQTL (FURIN rs4702) and four top-ranked SZ eQTL genes (FURIN, SNAP91, TSNARE1 and CLCN3), our platform resolves pre- and postsynaptic neuronal deficits, recapitulates genotype-dependent gene expression differences and identifies convergence downstream of SZ eQTL gene perturbations. Our observations highlight the cell-type-specific effects of common variants and demonstrate a synergistic effect between SZ eQTL genes that converges on synaptic function. We propose that the links between rare and common variants implicated in psychiatric disease risk constitute a potentially generalizable phenomenon occurring more widely in complex genetic disorders. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 N.S., S.-M.H., P.S., and K.J.B. contributed to experimental design. N.S. conducted all CRISPR editing experiments, assisted by M.R.-M., A.T. and S.A.; S.-M.H. completed all CRISPRa/i experiments. K.Y. and H.M. conducted and analyzed all CRISPRa/i electrophysiological experiments; N.S., S.-M.H. and M.R.-M. conducted all MEA experiments. E.C. generated CRISPR-edited organoids; P.J.M.D. generated CRISPR-edited NPCs. J.G., E.H. and H.P. provided LV-NFIA vectors. A.D., L.H., and E.A.S. conducted all genomic analyses; N.S. conducted all transcriptomic analyses, with critical advice from G.H. and E.F. All confocal imaging and semi-automated synaptic analyses were conducted by S.-M.H., M.R.-M., and N.B.; V.S., D.G. and B.A. conducted all automated high-content imaging analyses. K.A. and R.M. conducted kinome analysis. K.J.B., N.S. and S.-M.H. wrote the manuscript. AUTHOR CONTRIBUTIONS These authors contributed equally to this work. |
ISSN: | 1061-4036 1546-1718 |
DOI: | 10.1038/s41588-019-0497-5 |